Research Article Sangyong Jon Corresponding Author E-mail address: syjon@kaist.ac.kr Korea Advanced Institute of Science and Technology, Department of Biological Sciences, 291 Daehak-ro, Yuseong-gu, 34141 Daejeon, KOREA, REPUBLIC OF Search for more papers by this author Abstract Cancer nanovaccines that use nanomaterials as antigens and/or adjuvant‐delivering carriers can induce tumor antigen‐specific T cell immunity and have shown potential as therapeutic modalities in in vivo animal models.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile